These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10463321)

  • 1. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.
    Krystal JH; D'Souza DC; Karper LP; Bennett A; Abi-Dargham A; Abi-Saab D; Cassello K; Bowers MB; Vegso S; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1999 Jul; 145(2):193-204. PubMed ID: 10463321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.
    Krystal JH; Karper LP; Bennett A; D'Souza DC; Abi-Dargham A; Morrissey K; Abi-Saab D; Bremner JD; Bowers MB; Suckow RF; Stetson P; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1998 Feb; 135(3):213-29. PubMed ID: 9498724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
    Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
    Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol.
    Oranje B; Gispen-de Wied CC; Verbaten MN; Kahn RS
    Biol Psychiatry; 2002 Nov; 52(9):887-95. PubMed ID: 12399142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].
    Micallef J; Tardieu S; Gentile S; Fakra E; Jouve E; Sambuc R; Blin O
    Neurophysiol Clin; 2003 Jun; 33(3):138-47. PubMed ID: 12909392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
    Duncan GE; Leipzig JN; Mailman RB; Lieberman JA
    Brain Res; 1998 Nov; 812(1-2):65-75. PubMed ID: 9813244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
    D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E
    Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.
    Krystal JH; Bennett A; Abi-Saab D; Belger A; Karper LP; D'Souza DC; Lipschitz D; Abi-Dargham A; Charney DS
    Biol Psychiatry; 2000 Jan; 47(2):137-43. PubMed ID: 10664830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A
    Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
    Krystal JH; Madonick S; Perry E; Gueorguieva R; Brush L; Wray Y; Belger A; D'Souza DC
    Neuropsychopharmacology; 2006 Aug; 31(8):1793-800. PubMed ID: 16395307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations.
    Anderson PM; Pinault D; O'Brien TJ; Jones NC
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1895-904. PubMed ID: 24964190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine on precipitated opiate withdrawal.
    Jovaisa T; Laurinenas G; Vosylius S; Sipylaite J; Badaras R; Ivaskevicius J
    Medicina (Kaunas); 2006; 42(8):625-34. PubMed ID: 16963828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
    Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
    Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.